시장보고서
상품코드
1881487

강도 변조 방사선 치료(IMRT) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 방사선 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Intensity Modulated Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Radiation Type, By Application, By End User, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 185 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 강도 변조 방사선 치료(IMRT) 시장은 2024년에 20억 1,000만 달러로 평가되었으며, 2030년까지 CAGR 5.61%로 성장하여 27억 9,000만 달러에 달할 것으로 예측됩니다.

강도 변조 방사선 치료(IMRT)는 다수의 미세한 방사선 빔의 강도를 조절하여 종양에 정밀하게 방사선을 조사하는 첨단 방사선 치료 기술입니다. 이를 통해 종양의 형태에 맞게 조정하여 주변 정상 조직에 대한 노출을 최소화합니다. 시장 확대는 기본적으로 전 세계 각종 암 발생률의 증가와 환자의 삶의 질을 향상시키는 효과적이고 독성이 낮은 치료법에 대한 수요 증가에 의해 주도되고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 20억 1,000만 달러
시장 규모 : 2030년 27억 9,000만 달러
CAGR : 2025-2030년 5.61%
가장 빠르게 성장하는 부문 폐암
최대 시장 북미

주요 시장 촉진요인

전 세계 강도 변조 방사선 치료(IMRT) 시장은 암 발병률의 급격한 증가에 큰 영향을 받고 있습니다. 이는 첨단 정밀 치료법에 대한 수요를 근본적으로 견인하는 요인입니다. 전 세계적으로 신규 암 진단 건수가 증가함에 따라, 증가하는 환자 수를 관리하기 위해서는 IMRT와 같은 효과적인 치료 옵션이 필수적으로 요구되고 있습니다.

주요 시장 과제

강도 변조 방사선 치료(IMRT) 장비의 도입, 설치 및 지속적인 유지보수에 필요한 막대한 자본 투자는 세계 시장의 성장을 직접적으로 저해하고 있습니다. 이러한 막대한 재정적 부담은 특히 예산이 부족한 개발도상국의 의료 서비스 제공자들에게 큰 장벽이 되고 있습니다.

주요 시장 동향

저분할 강도 변조 방사선 치료(IMRT) 요법으로의 전환은 짧은 치료 기간 동안 1회당 방사선량을 증가시킬 수 있는 능력에 힘입어 전 세계 시장에서 중요한 추세입니다. 이러한 접근 방식은 환자의 편의성을 높이는 동시에 의료비 절감과 치료 접근성을 개선할 수 있는 잠재력을 가지고 있습니다.

자주 묻는 질문

  • 강도 변조 방사선 치료(IMRT) 시장 규모는 어떻게 예측되나요?
  • 강도 변조 방사선 치료(IMRT) 시장의 주요 성장 요인은 무엇인가요?
  • 강도 변조 방사선 치료(IMRT) 시장의 주요 과제는 무엇인가요?
  • 강도 변조 방사선 치료(IMRT) 시장의 주요 동향은 무엇인가요?
  • 강도 변조 방사선 치료(IMRT) 시장에서 가장 빠르게 성장하는 부문은 무엇인가요?
  • 강도 변조 방사선 치료(IMRT) 시장의 최대 시장은 어디인가요?

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 강도 변조 방사선 치료(IMRT) 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율과 예측
    • 방사선 유형별(양성자 치료, 전자선 치료, 광자선 치료, 탄소 이온선 치료)
    • 최종사용자별(병원·클리닉, 외래 수술 시설, 기타)
    • 용도별(전립선암, 폐암, 유방암, 뇌종양, 부인과암, 소화기암, 기타 암)
    • 지역별
    • 기업별(2024)
  • 시장 맵

제6장 북미의 강도 변조 방사선 치료(IMRT) 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 강도 변조 방사선 치료(IMRT) 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 강도 변조 방사선 치료(IMRT) 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 중동 및 아프리카의 강도 변조 방사선 치료(IMRT) 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 중동 및 아프리카 : 국가별 분석
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국

제10장 남미의 강도 변조 방사선 치료(IMRT) 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석
    • 브라질
    • 콜롬비아
    • 아르헨티나

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 인수합병
  • 제품 출시
  • 최근 동향

제13장 세계의 강도 변조 방사선 치료(IMRT) 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여의 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제15장 경쟁 구도

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems B.V.
  • Koninklijke Philips N.V.
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

The Global Intensity Modulated Radiotherapy Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 5.61% to reach USD 2.79 Billion by 2030. Intensity Modulated Radiotherapy (IMRT) is an advanced radiation therapy technique that precisely delivers radiation to tumors by modulating the intensity of numerous small radiation beams, thereby conforming to the tumor shape and minimizing exposure to surrounding healthy tissues. The market's expansion is fundamentally driven by the escalating global incidence of various cancer types, coupled with increasing demand for effective and less toxic treatment modalities that improve patient quality of life.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.01 Billion
Market Size 2030USD 2.79 Billion
CAGR 2025-20305.61%
Fastest Growing SegmentLung Cancer
Largest MarketNorth America

Key Market Drivers

The global Intensity Modulated Radiotherapy market is significantly influenced by the escalating global incidence of cancer, which fundamentally drives the demand for advanced and precise treatment modalities. The rising number of new cancer diagnoses worldwide necessitates effective therapeutic options like IMRT to manage the growing patient population. According to the American Cancer Society, in April 2024, in its "Global Cancer Statistics, 2024" report, an estimated 20 million cancer cases were newly diagnosed in 2022, underscoring the substantial and expanding need for oncology services.

Key Market Challenges

The significant capital investment required for Intensity Modulated Radiotherapy (IMRT) equipment acquisition, installation, and ongoing maintenance directly impedes the growth of the global market. This substantial financial outlay creates a considerable barrier, especially for healthcare providers in developing economies where budgets are frequently constrained. The high initial purchase price of sophisticated IMRT systems, coupled with expenses for specialized facility infrastructure, comprehensive training for technical staff, and continuous servicing contracts, places a heavy burden on healthcare systems.

Key Market Trends

The shift towards hypofractionated Intensity Modulated Radiotherapy regimens represents a significant trend in the global market, driven by its ability to deliver higher radiation doses per fraction over a shorter treatment period. This approach enhances patient convenience by reducing the number of hospital visits and overall treatment duration, while potentially lowering healthcare costs and improving access to care. According to an ASTRO 2024 report, approximately 7% of patients with intermediate-risk prostate cancer in the U. S. received hypofractionated regimens, indicating a substantial adoption rate in this patient cohort. This widespread acceptance is further supported by clinical evidence.

Key Market Players

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems B.V.
  • Koninklijke Philips N.V.
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intensity Modulated Radiotherapy Market, By Radiation Type:

  • Proton radiation
  • Electron radiation
  • Photon radiation
  • Carbon-lon radiation

Intensity Modulated Radiotherapy Market, By End User:

  • Hospital & Clinics
  • Ambulatory Surgical care
  • Others

Intensity Modulated Radiotherapy Market, By Application:

  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Brain cancer
  • Gynecological cancers
  • Gastrointestinal cancers
  • Other cancers

Intensity Modulated Radiotherapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Intensity Modulated Radiotherapy Market.

Available Customizations:

Global Intensity Modulated Radiotherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intensity Modulated Radiotherapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-lon radiation)
    • 5.2.2. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
    • 5.2.3. By Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Intensity Modulated Radiotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Radiation Type
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intensity Modulated Radiotherapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Radiation Type
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Intensity Modulated Radiotherapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Radiation Type
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Intensity Modulated Radiotherapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Radiation Type
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Application

7. Europe Intensity Modulated Radiotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Radiation Type
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Intensity Modulated Radiotherapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Radiation Type
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Application
    • 7.3.2. France Intensity Modulated Radiotherapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Radiation Type
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Intensity Modulated Radiotherapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Radiation Type
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Intensity Modulated Radiotherapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Radiation Type
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Intensity Modulated Radiotherapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Radiation Type
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Application

8. Asia Pacific Intensity Modulated Radiotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Radiation Type
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Intensity Modulated Radiotherapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Radiation Type
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Application
    • 8.3.2. India Intensity Modulated Radiotherapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Radiation Type
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Intensity Modulated Radiotherapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Radiation Type
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Intensity Modulated Radiotherapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Radiation Type
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Intensity Modulated Radiotherapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Radiation Type
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Application

9. Middle East & Africa Intensity Modulated Radiotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Radiation Type
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Intensity Modulated Radiotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Radiation Type
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Intensity Modulated Radiotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Radiation Type
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Intensity Modulated Radiotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Radiation Type
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Application

10. South America Intensity Modulated Radiotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Radiation Type
    • 10.2.2. By End User
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intensity Modulated Radiotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Radiation Type
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Intensity Modulated Radiotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Radiation Type
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Intensity Modulated Radiotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Radiation Type
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Intensity Modulated Radiotherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens Healthineers AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Accuray Incorporated
  • 15.3. Elekta GmbH
  • 15.4. Iba LLC
  • 15.5. Hitachi, Ltd.
  • 15.6. Mevion Medical Systems B.V.
  • 15.7. Koninklijke Philips N.V.
  • 15.8. Raysearch Laboratories AB
  • 15.9. Brainlab AG
  • 15.10. HD Biosciences Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제